AEON Biopharma, Inc. (AEON) Operating income 2021–2025
AEON Biopharma, Inc. (AEON) annual operating income history from SEC filings — each fiscal year as reported.
-$12.8MFY2025 · since FY2021: -$1.9M → -$12.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.8M | -117.5% |
| FY2024 | $73.0M | — |
| FY2022 | -$48.4M | -2401.6% |
| FY2021 | -$1.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice